Sweden· SE-19670622000023

Glucagon Novo Nordisk 1 mg (1 IE) Pulver och vätska till injektionsvätska, lösning i förfylld spruta

A glucagon product containing glucagon, registered in Sweden by Novo Nordisk A/S. The same ATC class is registered in 17 of our 19 countries.

ATC H04AA01

Checked against Swedish Medical Products Agency (Sweden) on October 1, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about glucagonAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Glucagon is registered in 17 of 19 countries.

Countries holding a registration under ATC H04AA01 (glucagon), each read from that country’s own register.

This record: Sweden, from Swedish Medical Products Agency (Sweden)
9 of them publish a price we can compare per daily dose

Search glucagon products by name

Glucagon · ATC H04AA01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glucagon costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Glucagon · price per daily dose (3 mg)

USD · FX 28 Sept 2026

CH Switzerland$104.78

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)

Active substance: Glucagon
Manufacturer: Novo Nordisk A/S
Country: Sweden (SE)
ATC code: H04AA01
ATC class: Glucagon
Defined daily dose: 3 mg, N
Reimbursed: Not published by this register
Source register: Swedish Medical Products Agency (Sweden)
Last checked: October 1, 2026

Packs & prices · 1

se_varunummer
19670622000023

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

22 interactions on record for glucagon.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check glucagon against other medicines How interaction checks work

Glucagon · interactions on record

22 records

1 moderate
21 minor

Most severe, free to view

IndometacinM01AB01moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glucagon in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glucagon products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Glucagen, Glucagen Hypokit
Belgium · Glucagen, Glucagen Hypokit
Bulgaria · Глюкаген Хипокит
Cyprus · Glucagen Hypokit
Czechia · Glucagen Hypokit
Germany · Glucagen, Glucagen Hypokit
Denmark · Glucagen, Glucagen Hypokit
Estonia · Glucagen Hypokit
Spain · Glucagen Hypokit
Finland · Glucagen
France · Glucagen, Glucagen Kit
Greece · Glucagen, Glucagen Hypokit
Croatia · Glucagen Hypokit
Hungary · Glucagen Hypokit
Ireland · Glucagen Hypokit
Iceland · Baqsimi, Glucagen
Italy · Glucagen, Glucagen Hypokit
Liechtenstein · Baqsimi
Lithuania · Glucagen Hypokit
Luxembourg · Glucagen, Glucagen Hypokit
Latvia · Glucagen Hypokit
Malta · Glucagen, Glucagen Hypokit
Netherlands · Glucagen, Hypokit
Norway · Baqsimi, Glucagon
Poland · Glucagen Hypokit
Portugal · Glucagen, Glucagen Hypokit
Romania · Glucagen Hypokit
Slovenia · Glucagen Hypokit
Slovakia · Glucagen Hypokit

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/7bf89bf6-3190-4343-b91e-3115529f4b01
GET /v1/drugs/7bf89bf6-3190-4343-b91e-3115529f4b01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL"
  ],
  "se_npl_id": "19670622000023",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19670622000023",
  "product_doc_link": "https://docetp.mpa.se/LMF/Glucagon%20Novo%20Nordisk%20powder%20and%20solvent%20for%20solution%20for%20injection%2C%20pre-filled%20syringe%20SmPC_09001bee807a3be1.pdf"
}

API reference MCP server Plans

See everything about glucagon.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console